Health
UC Davis uses microneedles to deliver gene therapy for retinal diseases – News-Medical.Net
A novel approach to delivering gene therapy for retinal diseases eliminates the need for complex eye surgery and treats more damaged cells than existing methods, a team of UC Davis physicians and veterinary eye specialists has found.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
A novel approach to delivering gene therapy for retinal diseases eliminates the need for complex eye surgery and treats more damaged cells than existing methods, a team of UC Davis physicians and veterinary eye specialists has found.
The research, led by associate professor of ophthalmology and vision sciences Glenn Yiu, involved microneedles that are a vast improvement over current methods that use viral particles to deliver genes to correct mutat…
-
Noosa News16 hours agoPill checking to resume in Queensland months after government axed funding
-
Business19 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business19 hours agoWhy Lynas, Mesoblast, PEXA, and Sayona Mining shares are tumbling today
-
Business19 hours agoBrokers name 3 ASX shares to buy today 29 August 2025